Volnay Therapeutics a private clinical stage cell and gene therapy company developing innovative hematology, oncology and immunology therapies that overcome current limitations of the field. Our portfolio is comprised of technologies that engineer smarter cells, drive better efficacy and safety, and can scale up for commercial success ranging from CAR-T, in vivo editing, T regs and programmable IFNα. We are looking for both out-licensing partnership for our existing portfolio, and in-licensing opportunities.